Background
==========

Recently, increasing research effort has been focused on the role of IR in age-related conditions or geriatric syndromes. The Italian InCHIANTI study, by examining community-dwelling elderly population, suggested that IR is associated with cognitive impairment as evidenced by poor performance in Trail Making Test and Mini-Mental State Examination \[[@B1],[@B2]\]. By following 3141 community-dwelling adults for 10 years, Barzilay and colleagues from the Cardiovascular Health Study demonstrated that IR is associated with incident frailty \[[@B3]\], a composite outcome consisting of involuntary weight loss, exhaustion, low physical activity, slowness, and weakness. With life expectancy reaching its historic pinnacle, decline in physical performance and the resultant late-life disability have become common features in an aging society \[[@B4]-[@B9]\]. However, data examining the association between IR and physical function are relatively sparse. We hypothesized that IR is inversely associated with physical function in community-dwelling elders. We sought to test the hypotheses by analyzing data from the NHANES 1999-2002.

Methods
=======

Study Design and Population
---------------------------

The NHANES, a population-based survey, used a stratified, multistage, and cluster sampling design to obtain a representative sample of the noninstitutionalized U.S. civilian population. NHANES consists of a detailed home interview and a health examination conducted in a mobile examination center (MEC). Datasets, Survey Operations Manuals, Consent Documents, and Brochures of the NHANES 1999-2002 are available on the NHANES website \[[@B10],[@B11]\].

A subsample of 2052 participants aged 50 years and older were randomly assigned to a morning session and had complete information of fasting plasma glucose and serum insulin. Individuals who had diabetes (physician-diagnosed history, fasting plasma glucose ≥ 126 mg/dL, or current use of diabetes medication; n = 434) or with missing values in the timed walking and isokinetic leg strength tests because of safety concerns (recent chest or abdominal surgery; heart attack in the past 6 weeks; brain aneurysm or stroke; current neck or back pain; difficulty in bending or straightening right knee; or right knee or right hip replacement) or any administrative, communicative, or technical problems (n = 450) were excluded from the analysis, leaving 1168 participants as the analytic sample. Among the final sample, median values of C-reactive protein (0.27 mg/dL, n = 1), vitamin B~12~(465.5 pg/mL, n = 2), folate (15.1 ng/mL, n = 3), total cholesterol (212 mg/dL, n = 2), cotinine (0.05 ng/mL, n = 24), as well as body mass index (27.12 kg/m2, n = 12) were used to impute missing values for these variables, all of which were used in the analysis.

Measures of IR
--------------

A blood sample was collected following an overnight fast (≥ 8 h) in participants who were assigned to a physical examination during a morning session. Plasma glucose level was measured with a hexokinase enzymatic reference method (COBRAS MIRA; Roche Diagnostics, Indianapolis, IN) and serum insulin level by a radio-immunoassay (Pharmacia Diagnostics, Uppsala, Sweden). Homeostasis model assessment of IR (HOMA-IR), an estimate of IR commonly applied in large epidemiological studies, was used to evaluate IR using the following formula: fasting serum insulin (μU/mL) × fasting plasma glucose (mmol/L)/22.5 \[[@B12]\].

Measures of habitual gait speed and isokinetic leg strength
-----------------------------------------------------------

Habitual gait speed (HGS) was measured in the MEC according to the NHANES standardized protocol. A 20 feet long test tract area was set up in a corridor of the MEC. The 20-foot walk was timed using a hand-held stopwatch. The 20-foot timed walk test was performed at the participant\'s usual pace. Use of a walker or cane was allowed if needed. HGS was calculated as walking distance (20 feet = 6.15 m) divided by time (second). Maximal right knee extensor force (Newton) was measured at an angular velocity of 60 degree/second by a Kinetic Communicator isokinetic dynamometer (Chattecx Corp., Chattanooga, TN).

Covariates
----------

Age, gender, and race/ethnicity were obtained by self-report. Co-morbidities including heart disease (defined as a history of myocardial infarction, coronary heart disease, congestive heart failure or angina), chronic lung disease (defined as chronic bronchitis or emphysema), and arthritis were ascertained by self-report questionnaires. Alcohol intake was determined by the questionnaire \"In any one year, have you had at least 12 drinks of any type of alcohol beverage?\" and was dichotomized. Exposure to tobacco smoke increases the concentration of nicotine in the blood, and nicotine is highly specific for such exposure. Cotinine is a major metabolite of nicotine. Using their serum cotinine concentrations (ng/mL), we classified smoking status of participants in four groups: nonsmoker (\<14), light smoker (14-99), moderate smoker (100-199), and heavy smoker (≥ 200) \[[@B13]\]. Three and sometimes 4 blood pressure (BP) determinations were taken using a mercury sphygmomanometer by a NHANES physician. BP was measured in the right arm unless specific conditions prohibit the use of the right arm. Averaged systolic and diastolic BPs were obtained. The presence of hypertension was defined by a self-report doctor\'s diagnosis, the use of anti-hypertensive medications, or averaged blood pressure greater than 140/90 mmHg. Body mass index (BMI), calculated as weight in kilograms divided by the square of height in meters, was categorized according to the National Institutes of Health obesity standards: \<18.5 = underweight, 18.5-24.9 = normal weight, 25.0-29.9 = overweight, and \>30 = obese \[[@B14]\]. C-Reactive protein (CRP) was quantified by utilizing latex-enhanced nephelometry with a Behring Nephelometer Analyzer System (Behring Diagnostics, Frankfurt, Germany). Plasma homocysteine was measured by the Abbott homocysteine assay (Abbott Park, IL, USA), a fully automated fluorescence polarization immunoassay (FPIA) method.

Analysis
--------

Data were analyzed using Stata 9.0 (Stata, College Station, TX) specialized for complex survey data. We used stratum and primary sampling unit (PSU) variables required for variance estimation. In order to account for clustering and stratification of the multi-stage NHANES sampling design, we incorporated appropriate sampling weight in all analyses in order to obtain point estimates and standard errors (SEs) applicable to the U.S. population. In the NHANES 1999-2002, separate 4-year fasting weights were created to reflect the additional stage of sampling and the additional nonresponse for the subsample of fasting participants assigned to the morning session. These 4-year fasting weights were used for data analysis.

Characteristics of the study population, including means and SEs values for continuous variables and percentages for categorical variables, were calculated with correction for the survey design in both men and women. Stratified by sex, weighted linear regression analysis was used to examine the relation of HOMA-IR to performance-based physical measures, namely leg strength and HGS. The distributions of HOMA-IR in both men and women were right-skewed. Therefore, we used natural-log-transformed values, which provided the best-fitting model for analysis in which the HOMA-IR were treated as a continuous variable. For men, standard-deviation scores of HOMA-IR were obtained from the formula (X~i~-X~m~) ÷ SD, where X~i~was the natural-log-transformed HOMA-IR in the individual male subject, X~m~the mean natural-log-transformed HOMA-IR in the male subjects, and SD the standard deviation of the natural-log-transformed HOMA-IR in the male subjects. The standard-deviation scores of HOMA-IR in women were obtained from the same formula. This calculation allowed us to determine the change in the gait speed and leg strength for each increment of 1SD in the natural-log-transformed HOMA-IR. The relations of HOMA-IR to leg strength and gait speed were also evaluated with a quartile-based analysis by dividing HOMA-IR levels into quartiles with subjects in the lowest quartile as the reference group. We used an extended-model approach for covariates adjustments: Model 1 = age, race, BMI, smoking status, alcohol consumption, and use of walking device; Model 2 = Model 1 + chronic diseases (hypertension, chronic lung disease, heart diseases, and arthritis); Model 3 = Model 2 + markers of nutrition and cardiovascular risk (natural-log-transformed levels of folate, vitamin B~12~, total cholesterol, homocysteine and CRP). Given the fact that muscle strength has been shown to be an important correlate for walking speed among community-dwelling older adults \[[@B15]\], we additionally controlled for leg strength in the association between HOMA-IR and HGS (Model 4) in order to observe possible change of association.

Results
=======

Table [1](#T1){ref-type="table"} lists the characteristics of the participants according to sex. The mean age among the 566 men was 61.8 years (age range 50 to 85 years), and among the 602 women it was 62.4 years (age range 50 to 85 years). The men had higher fasting plasma glucose, serum insulin, HOMA-IR, peak leg strength, as well as a higher prevalence of heart disease compared to women. The presence of hypertension, chronic lung disease, and arthritis was more common in women than in men. The men smoked more than the women and consumed more alcohol. The cut-off values for HOMA-IR quartiles among the men were: quartile 1 (\<1.80), quartile 2 (1.80-2.51), quartile 3 (2.52-3.69), and quartile 4 (\>3.69); while among the women they were quartile 1 (\<1.48), quartile 2 (1.48-2.28), quartile 3 (2.29-3.52), and quartile 4 (\>3.52). Men were comparable to women in terms of age, BMI, race, and HGS.

###### 

Characteristics of Study Participants NHANES 1999-2002 (N = 1168)

  ----------------------------------------------------------------------------------------------
  Characteristics                                    Men\            Women (N = 602)   P value
                                                     (N = 566)                         
  -------------------------------------------------- --------------- ----------------- ---------
  **[Continuous variables, Mean (SE)]{.ul}**                                           

   Age (year)                                        61.8 (0.4)      62.4 (0.3)        0.202

   Body mass index (kg/m2)                           27.9 (0.3)      27.7 (0.3)        0.752

   Fasting plasma glucose (mg/dL)                    101.0 (0.5)     97.4 (0.5)        \<0.001

   Serum insulin (μU/mL)                             11.72 (0.4)     10.52 (0.2)       0.001

   Insulin resistance (HOMA-IR)                      2.96 (0.1)      2.59 (0.1)        \<0.001

   Peak leg strength (Newton)                        439 (6.2)       299 (4.3)         \<0.001

   Habitual gait speed (m/sec)                       1.090 (0.013)   1.083 (0.011)     0.620

  **[Categorical variables, N (weighted %)]{.ul}**                                     

   Race                                                                                0.427

    Mexican American                                 104 (3.2)       114 (3.0)         

    Other Hispanic                                   22 (3.5)        28 (5.2)          

    Non-Hispanic White                               367 (85.9)      372 (83.5)        

    Non-Hispanic Black                               62 (4.8)        77 (5.8)          

    All others                                       11 (2.6)        11 (2.5)          

   Hypertension                                      294 (47.1)      387 (58.9)        0.001

   Heart diseases                                    73 (12.4)       50 (7.5)          0.017

   Chronic lung disease                              30 (4.4)        58 (11.4)         0.001

   Arthritis                                         184 (32.5)      278 (46.7)        \<0.001

   Smoking status                                                                      0.001

    Nonsmoker                                        429 (73.3)      514 (84.2)        

    Light smoker                                     22 (3.3)        14 (2.3)          

    Moderate smoker                                  39 (7.3)        35 (6.5)          

    Heavy smoker                                     76 (16.1)       39 (7.0)          

   Had \> 12 alcohol drinks/year                     464 (82.3)      314 (60.5)        \<0.001
  ----------------------------------------------------------------------------------------------

Values were expressed as mean (SEs) and number (weighted %)

HOMA-IR levels were inversely associated with HGS among the men. After adjustment for age, race, BMI categories, alcohol consumption, and use of walking devices, each increment of 1SD in the HOMA-IR level was associated with a 0.035 m/sec decrease (p = 0.007) in HGS (Table [2](#T2){ref-type="table"}). Additional adjustment of covariates including chronic co-morbidities and markers of nutrition/cardiovascular risk (folate, vitamin B12, total cholesterol, homocysteine, and CRP) did not change the association among men (Model 2 and Model 3). In the full-adjusted model where peak leg strength was additionally adjusted (Model 4), the negative association between HOMA-IR and HGS among men remained (β coefficient -0.042, p = 0.001). We did not find any association between HOMA-IR and HGS among the women. We subsequently divided HOMA-IR levels into quartiles and showed that HGS for men in the highest HOMA-IR quartile were 0.066 m/sec less than that for men in the lowest quartile after adjustment for Model 1 covariates (significant trend across HOMA-IR quartiles with p = 0.035). Likewise, supplementary adjustment for additional covariates (Models 2 to Model 4) did not change the inverse association between HOMA-IR and HGS among the men in the quartile-based analyses. We did not find a clear trend between HOMA-IR quartiles and HGS among the women. Stratified by gender, adjusted means of HGS based on different HOMA-IR quartiles were obtained from the full-adjusted regression models (Model 4) and illustrated in the Figure [1](#F1){ref-type="fig"}. We did not find any association between HOMA-IR and peak leg strength in both men and women (Data not shown).

![**Adjusted means of habitual gait speed v.s. quartiles of insulin resistance (HOMA-IR) in both men and women**.\* \* Means of habitual gait speed were adjusted for age, race, body mass index categories, smoking status, alcohol consumption, use of walking devices, co-morbidities (hypertension, chronic lung disease, heart disease, and arthritis), markers of nutrition and cardiovascular risk (natural-log-transformed levels of folate, vitamin B~12~, total cholesterol, homocysteine and C-reactive protein), and peak leg strength. Abbreviation: homeostasis model assessment of insulin resistance HOMA-IR.](1471-2318-9-49-1){#F1}

###### 

Association between insulin resistance (HOMA-IR) and gait speed in men and women

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
            Models with HOMA-IR as a continuous variable                                                                                                                
  --------- ------------------------------------------------- ---------------- ------------- ----------------- ------------------------- ---------------- ------------- -----------------
  Model 1                                                     -0.035 (0.013)   0.007                                                     -0.018 (0.013)   0.172         

  Model 2                                                     -0.033 (0.013)   0.010                                                     -0.014 (0.013)   0.289         

  Model 3                                                     -0.040 (0.013)   0.003                                                     -0.011 (0.013)   0.377         

  Model 4                                                     -0.042 (0.012)   0.001                                                     -0.012 (0.013)   0.364         

                                                                                                                                                                        

            **Models with HOMA-IR by increasing quartiles**                                                                                                             

                                                                                                                                                                        

            **Men**                                           **Women**                                                                                                 

                                                                                                                                                                        

            **Quartile comparison**                           **β†**\          **P value**   **P for trend**   **Quartile comparison**   **β†**\          **P value**   **P for trend**
                                                              **(SE)**                                                                   **(SE)**                       

                                                                                                                                                                        

  Model 1   Q2 v.s. Q1                                        -0.013 (0.026)   0.616         0.035             Q2 v.s. Q1                0.049 (0.027)    0.072         0.446

            Q3 v.s. Q1                                        -0.043 (0.029)   0.141                           Q3 v.s. Q1                -0.032 (0.031)   0.304         

            Q4 v.s. Q1                                        -0.066 (0.033)   0.046                           Q4 v.s. Q1                -0.001 (0.035)   0.987         

                                                                                                                                                                        

  Model 2   Q2 v.s. Q1                                        -0.010 (0.026)   0.711         0.056             Q2 v.s. Q1                0.052 (0.027)    0.057         0.521

            Q3 v.s. Q1                                        -0.039 (0.029)   0.177                           Q3 v.s. Q1                -0.025 (0.030)   0.403         

            Q4 v.s. Q1                                        -0.058 (0.033)   0.078                           Q4 v.s. Q1                0.004 (0.033)    0.905         

                                                                                                                                                                        

  Model 3   Q2 v.s. Q1                                        -0.015 (0.027)   0.567         0.024             Q2 v.s. Q1                0.055 (0.025)    0.042         0.700

            Q3 v.s. Q1                                        -0.046 (0.030)   0.120                           Q3 v.s. Q1                -0.020 (0.030)   0.504         

            Q4 v.s. Q1                                        -0.072 (0.033)   0.030                           Q4 v.s. Q1                0.013 (0.033)    0.702         

                                                                                                                                                                        

  Model 4   Q2 v.s. Q1                                        -0.006 (0.026)   0.786         0.019             Q2 v.s. Q1                0.051 (0.026)    0.054         0.663

            Q3 v.s. Q1                                        -0.039 (0.028)   0.167                           Q3 v.s. Q1                -0.018 (0.030)   0.556         

            Q4 v.s. Q1                                        -0.072 (0.032)   0.024                           Q4 v.s. Q1                0.008 (0.033)    0.807         
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Adjusted covariates:

Model 1 = Age, race, body mass index categories, smoking status, alcohol consumption, and use of walking devices

Model 2 = Model 1 + co-morbidities (hypertension, chronic lung disease, heart disease, and arthritis)

Model 3 = Model 2 + markers of nutrition and cardiovascular risk (natural-log-transformed levels of folate, vitamin B~12~, total cholesterol, homocysteine and C-reactive protein).

Model 4 = Model 3 + peak leg strength

\* Parameter estimates (β) can be interpreted as differences in mean gait speed (m/sec) for each increment of one standard deviation in the log transformed HOMA-IR among men (or women).

† Parameter estimates (β) can be interpreted as differences in mean gait speed (m/sec) compared male (or female) subjects in the 2^nd^, 3^rd^, and 4^th^quartiles of HOMA-IR to those in the lowest quartile.

Abbreviations: homeostasis model assessment of insulin resistance, HOMA-IR; SE, standard error.

The cut-off values HOMA-IR quartiles among the men were: quartile 1 (\<1.80), quartile 2 (1.80-2.51), quartile 3 (2.52-3.69), and quartile 4 (\>3.69); while among the women the cut-off values were: quartile 1 (\<1.48), quartile 2 (1.48-2.28), quartile 3 (2.29-3.52), and quartile 4 (\>3.52).

Discussion and conclusion
=========================

Among men without diabetes, there was an inverse association between IR and HGS. The relationship was independent of age, race, BMI, smoking status, alcohol consumption, co-morbidities, markers of nutrition and cardiovascular risk, and peak leg strength. Our findings support and extend previous studies examining the role of metabolic syndrome, a cluster of cardiovascular risk factors strongly associated with IR, in predicting the development of functional impairment. Supporting statements from Blazer and colleagues, by analyzing 1229 older adults from the Duke Established Populations for Epidemiologic Studies of the Elderly (EPESE), demonstrated that metabolic syndrome independently predicted mobility decline, as assessed by the ability to perform heavy housework unaided, walk up and down a flight of stairs unaided, and walk half a mile unaided\[[@B16]\]. Additionally, the population-based Sacramento Area Latino Study on Aging (SALSA) reinforced the fact that metabolic syndrome was associated with progressive limitations in mobility and strength by following 1606 Mexican Americans older adults for 3 years\[[@B17]\]. Okoro and colleagues, cross-sectionally examining the NHANES cohort, suggested that selected components of metabolic syndrome, specifically low HDL cholesterol and abdominal obesity, were associated with gait impairment\[[@B18]\]. Nevertheless, these studies may have weakness in internal validity because such important confounding factors as chronic inflammation \[[@B16]-[@B18]\], medical co-morbidities\[[@B16],[@B18]\], and nutritional status \[[@B16]-[@B18]\] were not considered. Furthermore, the reports of functional impairment are self-reported in Blazer et al\[[@B16]\] and Blaum et al\[[@B17]\], thus imposing potential bias in outcome ascertainment. Although metabolic syndrome, a composite outcome defined by expert panel\[[@B19]\], has recently attracted research interest, the usefulness of metabolic syndrome as an actual pathophysiological basis of functional decline has been questioned\[[@B20]\]. On the other hand, IR has been proposed as a principal factor in initiating and perpetuating the pathologic manifestations of the metabolic syndrome\[[@B21]\]. Unfortunately, none of the above studies scrutinize the role of IR in functional status. **The cross-sectional relation of IR to muscle strength has been evaluated in two population-based studies of community dwellers that highlighted an inverse association between IR and muscle strength**\[[@B22]-[@B24]\]. **However, such studies used different confounding variables in their statistical models and one of the studies consisted of a cohort entirely made up of men**\[[@B22]\]**which may explain the discrepancies from our findings**. To our knowledge, this is the first report to describe the association between IR and performance-based physical function among older men and women by using a large group of geographically dispersed and ethnically diverse national population-based sample. Potential confounders were comprehensively considered and the role of leg strength in the association between IR and gait speed was assessed.

By acting as a cardiovascular risk factor, IR may cause cerebral atherosclerotic changes in the cerebral circulation \[[@B25]\], **thus contributing to the development of cerebral micro-angiopathy (ie, leukoaraiosis or cerebral small vessel disease). The lesions may disrupt the integrity of frontal-subcortical circuits, thus compromising gait function**. Cerebrovascular lesions thus provide a conceivable mechanism between IR and slow gait speed. Since the association between IR and gait speed varies across gender, there may be an effect modification of sex in the association. **The fact that men had a greater baseline prevalence of cardiovascular risk (such as heart disease and smoking) than women may justify why an inverse association between IR and gait speed is seen in men but not in women**. Further research efforts are needed to investigate possible mediating factors, such as differential coordinating processes in brain neural circuiting or sex hormones\[[@B26]\], in mediating the effect of IR on gait speed. Our results have clinical implications. IR, in addition to its metabolic and cardiovascular implications, may serve as an important indicator of walking function among older man. As such, IR may be a promising target for intervention to prevent decline of walking function in late life. Secondly, pharmaceutical interventions such as metformin and thiazolidinedione \[[@B27]\], as well as additional known strategies to effectively lower IR- healthy dietary pattern \[[@B28]\], regular exercise \[[@B29]\], or weight reduction \[[@B30]\]- may **additionally**improve walking function and prevent functional decline, especially for high-risk subjects.

Our study has potential limitations deserving comments. First, due to the cross-sectional design, causal relationship between IR and gait speed can not be established. The association between IR and gait speed could simply be epiphenomenon of aging and the association should be prospectively explored. Second, although we have comprehensively adjusted for such confounders as chronic co-morbidities, markers of nutrition, inflammation, and cardiovascular risk, as well as leg strength in the association of IR and gait speed, other important measures such as cognitive ability, symptoms of depression, markers of endothelial dysfunction, or evidence of cerebral small vessel disease are absent or incomplete in the NHANES 1999-2002 dataset.

In conclusion, a higher level of IR was associated with a slower gait speed among non-diabetic older men. The association does not exist in the women. We provided new information for the association between IR and gait speed among community-dwelling older adults where data currently do not exist.
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